Healthcare sector expected to sustain growth momentum

Pharmaceutical players like Duopharma and Kotra were beneficiaries of stronger procurement activities from the public and private sectors and higher export sales in 2022.

PETALING JAYA: The healthcare and pharmaceutical sectors are expected to sustain their growth momentum through the reopening of international borders, higher procurement activities and better export sales, says RHB Research.

The research house noted the healthcare sector continues to see an rise in patient growth rate for the fourth quarter of 2022 (4Q22), with KPJ Healthcare Bhd (KPJ) and IHH Healthcare Bhd (IHH) delivering an increase of 2.3% and 33.1% year-on-year (y-o-y) respectively.